RICO Charge in Pharmaceutical Case May Signal Tougher Tactics – New York Times


New York Times
RICO Charge in Pharmaceutical Case May Signal Tougher Tactics
New York Times
The defendants are six former executives of Insys Therapeutics, an Arizona pharmaceutical company, including Michael L. Babich, who was chief executive from 2011 until November 2015. The company’s primary product is Subsys fentanyl, an opioid¬†…

and more >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd